FTSE 100 news / Companies and sectors / Convatec / 14 October 2026

Convatec (CTEC): news on Wednesday 14 October 2026

+0.3 neutral

Coverage was mixed: a former employee is seeking £366M in a patent profit-share claim and a costly InnovaMatrix write-down was discussed. Against that, the buyback, raised interim payout and 2026 guidance targets drew positive attention.

What drove it

patent profit-share claim
InnovaMatrix write-down
buyback and dividend

The 4 stories

Each headline's own score, strongest first. Links go to the publisher.

+8.7 Why ConvaTec's (LSE:CTEC) buyback and raised interim payout keep the FTSE 100 medtech on income radars kalkine.ca
Buyback and raised interim dividend are shareholder-friendly and positive.
−7.5 Ex-Convatec Worker Seeks £366M From Patent Profit Share Law360
Former worker seeking £366M patent profit share is a legal risk for Convatec.
+4.2 FTSE 100 Medtech Group Convatec (LSE:CTEC) Chronic Care Growth and Earnings Targets Keep 2026 Guidance in Focus Kalkine Media
Focus on chronic care growth and earnings targets with 2026 guidance intact.
−2.5 Does FTSE 100 Medtech Group Convatec (LSE:CTEC) Have The Growth Momentum To Shrug Off A Costly InnovaMatrix Write-Down? Kalkine Media
Costly InnovaMatrix write-down weighs, though growth momentum is questioned rather than lost.

Convatec: every day · Pharma and healthcare on 14 October 2026 · FTSE 100 overview for the day